Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY

v3.25.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings (Accumulated Deficit)
Beginning Balance (in shares) at Dec. 31, 2022   10,750,586      
Beginning Balance at Dec. 31, 2022 $ 247,077 $ 129 $ 460,660 $ (45,185) $ (168,527)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity-based compensation 7,640   7,640    
Issuance of common stock under employee equity plans, net of shares withheld (in shares)   137,801      
Issuance of common stock under employee equity plans, net of shares withheld (28)   (28)    
Repurchase of shares (in shares)   (320,506)      
Repurchase of shares (2,101) $ (1) (2,100)    
Cumulative translation adjustment (5,084)     (5,084)  
Net loss (98,886)       (98,886)
Ending Balance (in shares) at Dec. 31, 2023   10,567,881      
Ending Balance at Dec. 31, 2023 148,618 $ 128 466,172 (50,269) (267,413)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity-based compensation 7,980   7,980    
Issuance of common stock under employee equity plans, net of shares withheld (in shares)   232,805      
Issuance of common stock under employee equity plans, net of shares withheld (879)   (879)    
Repurchase of shares (in shares)   (131,037)      
Repurchase of shares (1,515)   (1,515)    
Cumulative translation adjustment (10,580)     (10,580)  
Net loss $ (25,990)       (25,990)
Ending Balance (in shares) at Dec. 31, 2024 10,669,649 10,669,649      
Ending Balance at Dec. 31, 2024 $ 117,634 $ 128 471,758 (60,849) (293,403)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity-based compensation 7,049   7,049    
Issuance of common stock under employee equity plans, net of shares withheld (in shares)   288,278      
Issuance of common stock under employee equity plans, net of shares withheld (707)   (707)    
Repurchase of shares (in shares)   (187,206)      
Repurchase of shares (1,976)   (1,976)    
Cumulative translation adjustment 7,205     7,205  
Net loss $ (31,434)       (31,434)
Ending Balance (in shares) at Dec. 31, 2025 10,770,721 10,770,721      
Ending Balance at Dec. 31, 2025 $ 97,771 $ 128 $ 476,124 $ (53,644) $ (324,837)